Literature DB >> 27980243

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Federico Bigazzi1, Maria Pia Adorni2, Mariarita Puntoni3, Francesco Sbrana1, Vincenzo Lionetti1,4, Beatrice Dal Pino1, Elda Favari2, Fabio A Recchia4,5, Franco Bernini2, Tiziana Sampietro1.   

Abstract

AIM: Circulating levels of high-density lipoprotein cholesterol (HDL-C) are decreased in patients with heart failure (HF). We tested whether HDL-C serum levels are associated with cardiac contractile dysfunction in a minipig HF model.
METHODS: Blood samples were collected from 13 adult male minipigs: 1) before pacemaker implantation, 2) 10 days after surgery, and 3) 3 weeks after high-rate LV pacing. Serum cholesterol efflux capacity (CEC), an index of HDL functionality, was assessed through four mechanisms: ATP Binding Cassette transporter A1 (ABCA1), ATP Binding Cassette transporter G1 (ABCG1), Scavenger Receptor-Class B Type I (SR-BI) and Passive Diffusion (PD).
RESULTS: HDL-C serum levels significantly decrease in minipigs with HF compared with baseline (p<0.0001). Serum CEC mediated by PD and SR-BI, but not ABCA1 or ABCG1, significantly decrease in animals with HF (p<0.05 and p<0.005, respectively). DISCUSSION: HDL-C serum levels and partial serum CEC reduction may play a pathophysiological role in the cardiac function decay sustained by high-rate LV pacing, opening new avenues to understand of the pathogenesis of nonischemic myocardial remodeling.

Entities:  

Keywords:  Cholesterol efflux; HDL; Minipig; Non-ischemic heart failure

Mesh:

Substances:

Year:  2016        PMID: 27980243      PMCID: PMC5556192          DOI: 10.5551/jat.37101

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  54 in total

Review 1.  Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?

Authors:  Nilima Shukla; John Maher; Joseph Masters; Gianni D Angelini; Jamie Y Jeremy
Journal:  Atherosclerosis       Date:  2006-01-10       Impact factor: 5.162

2.  Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Authors:  Danilo Neglia; Tiziana Sampietro; Cecilia Vecoli; Riccardo Liga; Giuseppe Rossi; Elena Filidei; Federico Bigazzi; Patricia Iozzo; Daniela Giannessi; Antonio L'Abbate; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2012-08-10       Impact factor: 5.952

Review 3.  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.

Authors:  Jonathan E Feig; Bernd Hewing; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

Review 4.  Large animal models of chronic heart failure (CHF).

Authors:  Jan D Schmitto; Suyog A Mokashi; Lawrence S Lee; Aron F Popov; Kasim O Coskun; Samuel Sossalla; Christian Sohns; R Morton Bolman; Lawrence H Cohn; Frederick Y Chen
Journal:  J Surg Res       Date:  2009-12-22       Impact factor: 2.192

5.  High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release.

Authors:  Laura Calabresi; Giuseppe Rossoni; Monica Gomaraschi; Francesca Sisto; Ferruccio Berti; Guido Franceschini
Journal:  Circ Res       Date:  2003-02-21       Impact factor: 17.367

Review 6.  Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations.

Authors:  Ilaria Zanotti; Elda Favari; Franco Bernini
Journal:  Curr Pharm Biotechnol       Date:  2012-02       Impact factor: 2.837

7.  Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure.

Authors:  Vincenzo Lionetti; Letizia Guiducci; Anca Simioniuc; Giovanni D Aquaro; Claudia Simi; Daniele De Marchi; Silvia Burchielli; Lorenza Pratali; Marcello Piacenti; Massimo Lombardi; Piero Salvadori; Alessandro Pingitore; Danilo Neglia; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-17       Impact factor: 4.733

8.  Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.

Authors:  Masahiko Iwaoka; Jyun-ei Obata; Makoto Abe; Takamitsu Nakamura; Yoshinobu Kitta; Yasushi Kodama; Ken-ichi Kawabata; Hajime Takano; Daisuke Fujioka; Yukio Saito; Tsuyoshi Kobayashi; Hideyuki Hasebe; Kiyotaka Kugiyama
Journal:  J Card Fail       Date:  2007-05       Impact factor: 5.712

9.  Inflammation, high density lipoprotein and endothelium.

Authors:  Sepideh Madahian; Kaveh Daniel Navab; Nasim Pourtabatabaei; Seyedehsara Seyedali; Sheila Safar; Samra Vazirian; Greg Hough
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 10.  Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Circ Heart Fail       Date:  2009-05       Impact factor: 8.790

View more
  2 in total

1.  Elastic aortic wrap reduced aortic stiffness by partially alleviating the impairment of cholesterol efflux capacity in pigs.

Authors:  Shutan Liao; Qing Zhou; Yang Zhang
Journal:  J Diabetes Metab Disord       Date:  2018-08-07

Review 2.  Cholesterol Efflux: Does It Contribute to Aortic Stiffening?

Authors:  Shutan Liao; Craig S McLachlan
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.